Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News N2OFF Inc NITO

N2OFF, Inc., an agri-food tech company, engages in the development and sale of eco-friendly green solutions for the food industry to enhance food safety and shelf life of fresh produce. The company’s products are based on proprietary blend of food acids combined with various oxidizing agent-based sanitizers and low concentrated fungicides for cleaning, sanitizing, and controlling pathogens on... see more

Recent & Breaking News (NDAQ:NITO)

N2OFF Advances $340,000 Payment to Gain Better Terms in Flag Solar Energy Initiative, Reflecting Approximately an Additional $1.7 Million in Project Profit Stake

GlobeNewswire 7 days ago

N2OFF Accelerates European Renewable Energy Momentum with Major De-Risking Milestones and Approximately $1.69 Million Value Unlock in Germany and Italy

GlobeNewswire December 29, 2025

N2OFF: MitoCareX Identifies Hit Compounds and Targets Preclinical Candidate Nomination

GlobeNewswire November 18, 2025

N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers

GlobeNewswire October 30, 2025

SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

GlobeNewswire October 23, 2025

N2OFF Announces Closing of Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

GlobeNewswire October 23, 2025

N2OFF Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire October 8, 2025

N2OFF Stockholders Approve Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

GlobeNewswire September 25, 2025

N2OFF Announces Reverse Stock Split

GlobeNewswire September 18, 2025

N2OFF Provides Business Update on Successful Execution of Solar and Energy Storage Initiatives Across Europe

GlobeNewswire September 18, 2025

N2OFF to Expand its Melz Solar Project with Battery Storage

GlobeNewswire September 11, 2025

N2OFF Completes $1.2 million of its $2.7 million Total Commitment to Finance 196MWp Battery Energy Storage Assets in Italy

GlobeNewswire July 11, 2025

N2OFF is Increasing its Investment in Melz Project to Explore Additional 40-60 MW Battery Storage

GlobeNewswire June 16, 2025

N2OFF Energy Targets European's Energy Crises with Fourth Regional Battery Project

GlobeNewswire May 15, 2025

N2OFF via Solterra Expands European Footprint with Entry into Fourth Project - a Battery Storage Venture in Poland

GlobeNewswire May 9, 2025

N2OFF Announces Potential to Maximize Investment Opportunity Following New Regulation in Germany

GlobeNewswire April 8, 2025

N2OFF Signs Non-Binding LOI for Potential 380MW Battery Energy Storage Projects

GlobeNewswire March 18, 2025

N2OFF Secures Definitive Agreement to Commercialize 196 MWp Battery Storage Projects

GlobeNewswire March 5, 2025

N2OFF Establishes a US Subsidiary for Its Solar PV Operations

GlobeNewswire March 3, 2025

N2OFF Signs Definitive Agreement to Acquire Next-Gen Computational Drug Discovery Company, Targeting Hard To Treat Cancers

GlobeNewswire February 26, 2025